Drug lookup
Drug reference

typhoid-paratyphoid a, b vaccine

Killed (Inactivated) bacterial vaccine · Vaccine for typhoid/paratyphoid

Killed (Inactivated) bacterial vaccineVaccine for typhoid/paratyphoid
CDSCO approved
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
not curated

Mechanism

The vaccine is a sterile suspension containing S. typhi and S. paratyphi A and B organisms. It acts as an antigen which induces the production of specific antibodies by the recipient.

Indications

Prevention of enteric fever

Dosing

Adult
0.5 ml s.c., 2–3 injections at 2–4 weeks intervals. Booster doses may be given every 2–3 years.
Pediatric
0.5 ml s.c., 2–3 injections at 2–4 weeks intervals. Booster doses may be given every 2–3 years.

Pharmacokinetics

Duration
1 year

Side effects

Common
Local tendernessFeverMalaise (lasting 1–2 days after first dose)

Related guidelines

Other Killed (Inactivated) bacterial vaccine drugs

Ask House about typhoid-paratyphoid a, b vaccine

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team